Researchers Submit Patent Application, "Lysin Cf-301 Resensitizes Methicillin-Resistant Staphylococcus Aureua (Mrsa) To Penicillin Derivatives And First Generation Cephalosporins", for Approval (USPTO 20210260070).

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Source:
    Medical Patent Business Week. 2021, pages. 8280